about
The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cellsMuir-Torre-like syndrome in Fhit-deficient miceMolecular Targeted Intervention for Pancreatic CancerMouse models of pancreatic cancerPancreatic biomarkers: could they be the answer?Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells.Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokineImaging cancer gene activity in patients from outside the bodyDetection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probesReduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype.Pdx-1-driven overexpression of aurora a kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice.Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinomaFAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancer.Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
P2860
Q24528155-3202CF9C-9099-4B77-9494-6C56CF3E428CQ24676755-7CC23181-8822-4646-A24F-3AD84F918325Q26798453-92441723-3E3D-4215-B975-A5DE7C585B70Q26860574-D5FE8A08-14EA-4F31-BBDD-42C9C9B2B542Q33801371-E2B403BC-C27D-43EB-8E3B-4732492C96B2Q34354462-441BDA64-8FB1-467B-A8AB-08F617A7003FQ35607235-C55B1F3C-ED35-431E-B041-FD91D73ECABBQ35609031-C84A2817-1781-4F78-8CB8-6A0393638608Q36606236-763AE39A-DD9E-4467-9406-F4D2DCAFE143Q36616092-FC40D573-6987-4B3C-8613-4FA3924FAF5DQ36645962-87177E41-57D9-43AD-84F4-70550099A3C7Q36694564-3E3AD252-F251-406E-BA45-1B79D56C81D2Q37309570-981571B0-6388-4DDF-BA61-2FE1AE2FD555Q37340505-093B4123-FEF1-4A3F-8B98-E3E1128438EEQ37717226-13051CA7-3358-4DFD-93DA-17DF4D875AEBQ38309871-6F6D94AB-7BF3-41E2-A94F-BEDD98C519E5Q47620397-A17CAA41-EDF5-43BA-885D-5FDBE11B8D02
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular genetic basis of pancreatic adenocarcinoma.
@ast
Molecular genetic basis of pancreatic adenocarcinoma.
@en
type
label
Molecular genetic basis of pancreatic adenocarcinoma.
@ast
Molecular genetic basis of pancreatic adenocarcinoma.
@en
prefLabel
Molecular genetic basis of pancreatic adenocarcinoma.
@ast
Molecular genetic basis of pancreatic adenocarcinoma.
@en
P1476
Molecular genetic basis of pancreatic adenocarcinoma.
@en
P2093
P356
10.1002/(SICI)1098-2264(199909)26:1<1::AID-GCC1>3.3.CO;2-O
P577
1999-09-01T00:00:00Z